Laske, Reiner and Meindl, Wolfgang and Holler, Eggehard and Schönenberger, Helmut (1989) Investigations on the mode of action of antimycobacterial benzylamines. Archiv der Pharmazie 322 (5), pp. 297-299.
Full text not available from this repository.
The antimyobacterial effects of benzylamines were found not to be related to inhibition of aminoacyl-tRNA synthetases.
|Additional information (public):||CAN 111:93770 10-5 Microbial Biochemistry 9055-66-7 (Phenylalanyl-tRNA synthetase) Role: PROC (Process) (inhibition of, of Mycobacterium tuberculosis by benzylamines, antibacterial activity in relation to); 15062-72-3; 90389-22-3; 90389-32-5 Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (tuberculostatic activity of, aminoacyl-tRNA synthetase inhibition in relation to)|
|Institutions:||Chemistry and Pharmacy > Institute of Pharmacy > Retired Professors > Prof. Schönenberger|
|Keywords:||Tuberculostatics (benzylamines as, amino acyl-tRNA synthetase inhibition in relation to) Escherichia coli (benzylamines inhibition of growth and amino acyl-tRNA synthetases of) Mycobacterium tuberculosis (benzylamines inhibition of, mechanism of) Kinetics (of inhibition, of phenylalanyl-tRNA synthetases of Mycobacterium tuberculosis and Escherichia coli) bactericide benzylamine aminoacyl tRNA synthetase inhibition bacteria aminoacyl tRNA synthetase inhibition benzylamine benzylamine antimycobacterial activity mechanism mycobacteria sensitivity benzylamine mechanism|
|Subjects:||500 Science > 540 Chemistry & allied sciences|
|Refereed:||Yes, this version has been refereed|
|Created at the University of Regensburg:||Unknown|
|Deposited On:||22 Nov 2010 12:34|
|Last Modified:||22 Nov 2010 12:34|